ZANAMIVIR HYDRATE

Modify Date: 2024-02-18 19:24:18

ZANAMIVIR HYDRATE Structure
ZANAMIVIR HYDRATE structure
Common Name ZANAMIVIR HYDRATE
CAS Number 171094-50-1 Molecular Weight 350.325
Density N/A Boiling Point N/A
Molecular Formula C12H22N4O8 Melting Point N/A
MSDS N/A Flash Point N/A

 Use of ZANAMIVIR HYDRATE


Zanamivir hydrate (5:1) is the hydrate of Zanamivir. Zanamivir is an influenza viral neuraminidase inhibitor with IC50 values of 0.95 nM and 2.7 nM for influenza A and B, respectively[1].

 Names

Name ZANAMIVIR HYDRATE
Synonym More Synonyms

 ZANAMIVIR HYDRATE Biological Activity

Description Zanamivir hydrate (5:1) is the hydrate of Zanamivir. Zanamivir is an influenza viral neuraminidase inhibitor with IC50 values of 0.95 nM and 2.7 nM for influenza A and B, respectively[1].
Related Catalog
Target

IC50: 0.95 nM (Influenza A); 2.7 nM (Influenza B)[1]

In Vivo Zanamivir has a poor bioavailability in oral administration, with only 4–17% of the agent. Oral delivery of Zanamivir has been a problem due to its strong hydrophilic nature that limits its transport across the intestinal epithelium. Permeation enhancers such as sodium cholate, hydroxypropyl β-cyclodextrin could be used with zanamivir to enhance the intestinal permeability[3].
References

[1]. Gubareva LV, et al. Comparison of the activities of zanamivir, oseltamivir, and RWJ-270201 against clinical isolates ofinfluenza virus and neuraminidase inhibitor-resistant variants. Antimicrob Agents Chemother. 2001 Dec;45(12):3403-8.

[2]. McKimm-Breschkin JL, et al. Management of influenza virus infections with neuraminidase inhibitors: detection, incidence, and implications of drug resistance. Treat Respir Med. 2005;4(2):107-16.

[3]. Shanmugam S, et al. Zanamivir oral delivery: enhanced plasma and lung bioavailability in rats. Biomol Ther (Seoul). 2013 Mar;21(2):161-9.

 Chemical & Physical Properties

Molecular Formula C12H22N4O8
Molecular Weight 350.325
Exact Mass 350.143768

 Synonyms

D-glycero-D-galacto-Non-2-enonic acid, 5-(acetylamino)-4-[(aminoiminomethyl)amino]-2,6-anhydro-3,4,5-trideoxy-, hydrate (1:1)
ZANAMIVIR HYDRATE
D-glycero-D-galacto-Non-2-enonic acid, 5-(acetylamino)-4-[(aminoiminomethyl)amino]-2,6-anhydro-3,4,5-trideoxy-, hydrate (5:1)
MFCD03791324
(6R)-5-Acetamido-2,6-anhydro-4-carbamimidamido-3,4,5-trideoxy-6-[(1R,2R)-1,2,3-trihydroxypropyl]-L-threo-hex-2-enonic acid hydrate (1:1)